Modified Cortex Mori Capsules improving the successful rate of functional filtering blebs after reclinical glaucoma filtering surgery

Figure 1 Four types of filtering bleb were diagnosed. A: Type I (small cystic type): Thin capsule wall, no vessels with tiny cystic; B: Type II (flat diffuse type): Thicker capsule wall, flat, diffuse and pale filtering bleb; C: Type III (scar type): No filtering bleb or conjunctiva congestion, rich vessels and scarring on the filtering bleb; D: Type IV (package type): Cystic hyperplasias, limitations of uplift filtering bleb.

Figure 2 Histogram shows percentage comparisons of the functional bleb and success rate of operation after 6 mo. Comparison between Modified Cortex Mori Capsules and placebo group were significantly different (^aP < 0.05). MCMC: Modified Cortex Mori Capsules.

Figure 3 The rate of functional filtering bleb. MCMC: Modified cortex mori capsules.

Figure 4 Dynamic changes of intraocular pressure during pre-operation and postoperation at different time points. The results showed that the intraocular pressure level is similar pre-operation between the Modified Cortex Mori Capsules group and the placebo group. During the post-operative period, the IOP levels in the Modified Cortex Mori Capsules group were lower than the placebo but not significantly (P > 0.05). IOP: Intraocular pressure; MCMC: Modified Cortex Mori Capsules.